April 23 (Reuters) - Abionyx Pharma SA ABNX.PA :
* Q1 GROSS CASH POSITION OF €9.0 MILLION AS AT MARCH 31TH,
2020
* DELAY IN ANNOUNCEMENT OF STRATEGIC PLAN
* CASH AND CASH EQUIVALENTS STOOD AT €9.0 MILLION AT 31
MARCH 2020
* FINANCIAL RESOURCES COMBINED WITH TEMPORARY ABSENCE OF
FINANCIAL
COMMITMENTS RELATED TO CLINICAL DEVELOPMENTS ALLOW CO TO ADAPT
TO COVID-19
Source text for Eikon: ID:nBw7MsfYna
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))